Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination.

Koya T, Date I, Kawaguchi H, Watanabe A, Sakamoto T, Togi M, Kato T Jr, Yoshida K, Kojima S, Yanagisawa R, Koido S, Sugiyama H, Shimodaira S.

Pharmaceutics. 2020 Mar 28;12(4). pii: E305. doi: 10.3390/pharmaceutics12040305.

2.

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia.

Saito S, Taira C, Matsuda K, Yanagisawa R, Morita D, Shigemura T, Yoshikawa K, Tanaka M, Sakashita K, Mukai S, Shimodaira S, Koike K, Nakazawa Y.

Leuk Lymphoma. 2020 Apr;61(4):967-970. doi: 10.1080/10428194.2019.1697813. Epub 2019 Dec 6. No abstract available.

PMID:
31809628
3.

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H.

Vaccines (Basel). 2019 Sep 19;7(3). pii: E120. doi: 10.3390/vaccines7030120.

4.

Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.

Yamanaka M, Yanagisawa R, Kojima S, Nakazawa H, Shimodaira S.

Transfusion. 2019 Nov;59(11):3405-3412. doi: 10.1111/trf.15527. Epub 2019 Sep 18.

PMID:
31532542
5.

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.

Ito Z, Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido S.

Oncology. 2019;97(3):135-148. doi: 10.1159/000500359. Epub 2019 Jun 19.

PMID:
31216557
6.

Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients.

Kojima S, Yanagisawa R, Tanaka M, Nakazawa Y, Shimodaira S.

Transfusion. 2018 Dec;58(12):2952-2958. doi: 10.1111/trf.14917. Epub 2018 Oct 6.

PMID:
30291756
7.

Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.

Kanai T, Ito Z, Oji Y, Suka M, Nishida S, Takakura K, Kajihara M, Saruta M, Fujioka S, Misawa T, Akiba T, Yanagisawa H, Shimodaira S, Okamoto M, Sugiyama H, Koido S.

Oncol Lett. 2018 Aug;16(2):2682-2692. doi: 10.3892/ol.2018.8961. Epub 2018 Jun 13.

8.

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

Hirabayashi K, Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2227-2234.

PMID:
29599343
9.

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.

Yanagisawa R, Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2217-2225.

PMID:
29599342
10.

Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.

Koido S, Okamoto M, Kobayashi M, Shimodaira S, Sugiyama H.

Discov Med. 2017 Aug;24(130):41-49. Review.

11.

Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.

Koya T, Yanagisawa R, Higuchi Y, Sano K, Shimodaira S.

Sci Rep. 2017 Feb 13;7:42145. doi: 10.1038/srep42145.

12.

Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.

Koido S, Okamoto M, Shimodaira S, Sugiyama H.

Immunotherapy. 2016 Nov;8(11):1309-1320. Review.

PMID:
27993090
13.

Dendritic Cell-Based Cancer Immunotherapy Targeting Wilms’ Tumor 1 for Pediatric Cancer.

Shimodaira S, Hirabayashi K, Yanagisawa R, Higuchi Y, Sano K, Koizumi T.

In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 8.

14.

Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis.

Takahashi H, Shimodaira S, Ogasawara M, Ota S, Kobayashi M, Abe H, Morita Y, Nagai K, Tsujitani S, Okamoto M, Suzuki Y, Nakanishi Y, Yonemitsu Y; DC Vaccine Study Group at the Japanese Society of Immunotherapy and Cell Therapy.

Cancer Immunol Immunother. 2016 Sep;65(9):1099-111. doi: 10.1007/s00262-016-1872-z. Epub 2016 Jul 22.

PMID:
27448677
15.

Transfusion-related acute lung injury in an infant.

Yanagisawa R, Takeuchi K, Kurata T, Sakashita K, Shimodaira S, Ishii E.

Pediatr Int. 2016 Jun;58(6):543-4. doi: 10.1111/ped.12951. No abstract available.

PMID:
27322867
16.

Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.

Kajihara M, Takakura K, Kanai T, Ito Z, Matsumoto Y, Shimodaira S, Okamoto M, Ohkusa T, Koido S.

World J Gastroenterol. 2016 May 14;22(18):4446-58. doi: 10.3748/wjg.v22.i18.4446. Review.

17.

Dendritic cell-based cancer immunotherapy for colorectal cancer.

Kajihara M, Takakura K, Kanai T, Ito Z, Saito K, Takami S, Shimodaira S, Okamoto M, Ohkusa T, Koido S.

World J Gastroenterol. 2016 May 7;22(17):4275-86. doi: 10.3748/wjg.v22.i17.4275. Review.

18.

Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms' Tumor 1 in Patients with Advanced Colorectal Cancer.

Shimodaira S, Sano K, Hirabayashi K, Koya T, Higuchi Y, Mizuno Y, Yamaoka N, Yuzawa M, Kobayashi T, Ito K, Koizumi T.

Vaccines (Basel). 2015 Dec 11;3(4):1004-18. doi: 10.3390/vaccines3041004.

19.

Enzyme-Linked Immunosorbent Spot Assay for the Detection of Wilms' Tumor 1-Specific T Cells Induced by Dendritic Cell Vaccination.

Higuchi Y, Koya T, Yuzawa M, Yamaoka N, Mizuno Y, Yoshizawa K, Hirabayashi K, Kobayashi T, Sano K, Shimodaira S.

Biomedicines. 2015 Dec 4;3(4):304-315. doi: 10.3390/biomedicines3040304.

20.

Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.

Yanagisawa R, Nakazawa Y, Sakashita K, Saito S, Tanaka M, Shiohara M, Shimodaira S, Koike K.

Int J Hematol. 2016 Jan;103(1):107-11. doi: 10.1007/s12185-015-1902-1. Epub 2015 Nov 19. Review.

PMID:
26586462

Supplemental Content

Loading ...
Support Center